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Background: Habitual physical activity (HPA) is believed to contribute to overall ﬁtness in CF, however little is known about HPA patterns in adults.
Methods: Adults with CF were recruited from a tertiary hospital outpatient clinic and were compared with controls without CF. HPA was measured
as MET·minutes·week−1 using the long-form International Physical Activity Questionnaire. The relationship between HPA and lung function was
explored.
Results: CF-group, n=101 [45% females, mean(sd) age=29(9), FEV1 % pred=60(23)] and controls, n=35 [69% females, age 32(10), FEV1 %
pred=101(130)]. Both groups reported similar levels of moderate and vigorous activities but the CF-group accumulated signiﬁcantly less total
HPA than controls, mean(sd)=5309(6277) vs. 7808(5493), due to less HPA associated with work, 1887(4285) vs. 3707(5292) and transport
613(1018) vs. 1315(1123). Females with CF showed low to moderate correlations of HPA with lung function (R from 0.30 to 0.42, pb0.05).
Conclusions: Adults with CF accumulate less HPA than non-CF peers. Work and transportation form important targets through which physical
activity may be accumulated to supplement prescribed exercise. In females with CF, declining physical activity seen in older adolescents carries
into adulthood, which may have implications for wellbeing and outcome.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic ﬁbrosis; Physical activity; Adults1. Background
Cystic fibrosis (CF) is characterised by progressive deteriora-
tion of lung function, and an associated decrease in exercise
tolerance and fitness. Exercise training in this patient population
is an important part of ongoing management and high levels of
fitness are associated with better survival [1,2]. Further, exercise
training may augment sputum clearance when combined with
airway clearance therapy techniques [3]. The benefits of exercise⁎ Corresponding author at: Physiotherapy Department, The Alfred Hospital
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;lishedare traditionally realised through structured exercise training aimed
at improving physical fitness and slowing pulmonary deterioration
[4]. It is recommended that patients undertake exercise on most
days of the week [1]. However formal structured exercise is often a
challenge to sustain [5,6], especially outside the realms of
supervised settings [7]. Previous studies have reported compliance
with healthcare professional prescribed exercise regimen rates of
21–37% in patients with CF [8,9]. These figures suggest that the
majority of patients do not achieve optimum levels of physical
activity as advised by their healthcare providers.
Being part of normal day to day activity, habitual physical
activity (HPA) may be a useful option for maintaining and
sustaining exercise tolerance beyond the supervised setting.
In children and adolescents with worse lung disease, fitnessby Elsevier B.V. All rights reserved.
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vigorous activities [10]. This would suggest that HPA may
contribute to fitness. Survival rates in CF are improving [11]
and with advancements in medical and allied health care,
more patients survive into adulthood [12]. Previous studies
on physical activity behaviours and patterns have largely
focussed on children and adolescents [5,10,13,14]. There is
limited attention to habitual physical activity and how it
interacts with health status in the adult CF population.
During their younger years, people with CF perform physical
activity at levels that are similar to their healthy peers, but this
starts to decline when they reach adolescence [10,13]. Habitual
physical activity is reported to be associated with respiratory
function, and low activity levels are associated with a rapid
decline in FEV1 especially in females [14]. Thus it is pertinent to
gain an understanding of HPA amongst the adult CF population
in order to inform continued exercise prescription as well as to
support and promote HPA as an adjunct to a structured fitness
promoting regimen.2. Aim
This study aimed to evaluate habitual physical activity levels
among adults with CF compared with a healthy non-CF aged
matched group.Table 1
Participant characteristics.
CF (n=101) Non-CF (n=35) p
Age, years 29 (9) 32 (10) 0.098
Gender females/males, % 45/55 69/31 0.018
Weight, kg 63 (16) 68 (14) 0.041
Height, m 1.68 (0.10) 1.71 (0.09) 0.137
BMI, kg·m−2 22.3 (4.2) 23.2 (3.2) 0.038
Lung function
FEV1 (litres) 2.17 (0.97) 3.52 (0.70) b0.001
FEV1 % predicted 60.1 (23.1) 100.9 (12.8) b0.001
FVC (Litres) 3.40 (1.16) 4.13 (0.83) b0.001
FVC % predicted 79.7 (19.9) 100.9 (12.8) b0.001
FEV1/FVC 62.9 (13.8) 85.6 (7.5) b0.001
Resting SpO2, % 95 (2) 97(1) b0.001
Resting HR, bpm 90 (12) 71(10) b0.001
Pulmonary impairment (%)
Nil 23 97
Mild 21 3
Moderate 34 0
Severe 23 0
Continuous variables presented as mean(SD).3. Methods
A prospective sample of adult patients with CF was recruited
from the CF outpatient clinic at a tertiary hospital (Alfred
Hospital, Melbourne Australia). In order to be eligible for
inclusion, participants had to have a diagnosis of cystic fibrosis,
be 18 years old and over, and be clinically stable. A non-CF
control group of healthy adults was recruited via flyers at the
Alfred Hospital and most respondents were staff from the
hospital. To be eligible for inclusion, the non-CF respondents
needed to be at least 18 years of age and have no underlying
cardiorespiratory condition.
Consenting participants completed the long version, 7-day
recall International Physical Activity Questionnaire (IPAQ). The
IPAQ measures total time of habitual physical activities that are
work, transport, domestic and leisure related. Activities are
included if performed for at least 10 min at a time. The IPAQ
captures the time and number of days spent on vigorous,
moderate and walking activities in the previous week. The
estimated time and number of days are then converted to
weighted MET·minutes per week (MET·min ·week−1) [15].
Physical activity is also scored as high, moderate or low and the
criteria for each category are defined in IPAQ scoring protocol
[16]. Prior to the study we evaluated the criterion validity of the
IPAQ against the ActiGraph GT1M accelerometer (Actigraph,
Pensacola, Florida) worn for 7 days in 30 of the participants with
CF. There was a significant relationship between weekly caloric
energy expenditure (EE) measured on the Actigraph and that
measured by the IPAQ (r=0.46, p=0.010) [17]. Criterion
validation of the IPAQ in a general population has alsoshown moderate correlations with accelerometer measure-
ments (r=0.33, 95% CI: 0.26, 0.39) [15].
Lung function, height and weight were recorded for both
groups. Pulmonary impairment was classified as mild (FEV1
60–79% predicted), moderate (FEV1 41–59% predicted) or
severe (FEV1≤40% predicted) [18]. Sputum colonisation and
CF genotype were recorded for the CF group. The proportions
of each group who met the physical activity recommendations
[6] of 150 min per week of walking, moderate or vigorous
intensity physical activity were compared.
Continuous variables were summarised as means and standard
deviations, and percentages were calculated for categorical
variables. Univariate tests of association were performed using
partial correlation statistics, with CF diagnosis as a control
variable. The Mann–Whitney U test was used to compare the
groups on IPAQ physical activity and other continuous variables.
Further comparisons between the IPAQ domains within groups
were made using the Friedman test. Association between
categorical variables was tested with chi-square test for indepen-
dence. pb0.05 indicated statistical significance.
4. Results
The CF group had 101 participants while the non-CF
group had 35 participants. Their demographic characteristics
are presented in Table 1. The CF group represented 43% of
our clinic population and their demographic characteristics
were not significantly different from the remainder of our
clinic. Homozygous DF508 mutation (53%) was the predom-
inant CF genotype, while 15% were heterozygous DF508 and
the remaining 32% had other genotypes or the results were
not available. Pseudomonas was the most common respiratory
organism (61% of CF group), 7% had no growth in cultures while
the remaining 32% had colonisation from multiple organisms
Table 3
Pearson correlation coefficients for HPA and lung function in females with CF.
Total Work Transport Domestic Total
walking
Total
vigorous
activity
FEV1 0.26 0.29 −0.05 0.18 −0.08 0.31 ⁎
FEV1 % predicted 0.29 0.32 ⁎ −0.07 0.22 −0.06 0.34 ⁎
FVC 0.33 ⁎ 0.21 0.29 0.25 0.20 0.32 ⁎
FVC % predicted 0.42 ⁎ 0.30 ⁎ 0.28 0.34 ⁎ 0.22 0.42 ⁎
FEV1/FVC 0.07 0.25 −0.40⁎⁎ 0.01 −0.32 ⁎ 0.16
FEV1/FVC %
predicted
0.07 0.24 −0.39⁎ 0.01 −0.31 ⁎ 0.17
⁎ pb0.05.
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percent in the CF group (vs. 94% in the non-CF group) engaged
in paid or unpaid employment.
Table 2 presents weekly physical activity in MET·min·
week−1. The two groups reported similar energy expenditure
accumulated from moderate or vigorous physical activity. In
comparison to their non-CF counterparts, participants with CF
reported significantly less overall physical activity, as well as
work and transport related physical activity. Seventy six
percent of those in the CF group reported performing vigorous
tasks at work, compared to. 88% of controls (chi-sq=1.95, df=
1, p=0.197). The groups differed significantly on physical
activity acquired from walking, with the CF group less active.
Groups were comparable on domestic and leisure-related
physical activities. There were no differences between CF and
control groups in the proportion who achieved 150 min per
week of walking, moderate or vigorous physical activity (93%
in each group, p=0.97).
Participants with CF were less likely to acquire their weekly
physical activity through transport-related activities (Table 2)
compared to other domains (Friedman test pb0.001). Of the three
activity types (vigorous activities, moderate activities and
walking) the non-CF group achieved a greater proportion of
their total physical activity from vigorous activities (p=0.001),
whereas those with CF had a similar contribution from all activity
intensities (p=0.178). In both the CF and control groups there
were no statistically significant differences (pN0.05) between
males and females on IPAQ total and domain scores, indicating
that females with CF were equally as active as males. The trend
was higher scores for males than females, the exception being
domestic chores in which females accumulated more physical
activity than males.
For the entire group, higher levels of physical activity were
significantly associated with better respiratory function, how-
ever the relationships were weak (Pearson R from 0.18 to 0.23,
pb0.05). In females with CF, lower levels of HPA were
associated with lower lung function (Table 3). The relationship
between HPA and lung function was not statistically significant
in males with CF or in the non-CF cohort.
The majority of participants in each group had overall
physical activity scores which classified them in the high HPA
category (Fig. 1). A greater percentage of the non-CF cohortTable 2
MET·min·week−1 of physical activity measured with the IPAQ.
MET·min·week−1, mean (sd)
CF Non-CF p ⁎
IPAQ total 5309 (6277) 7808 (5493) 0.011
Work 1887 (4285) 3707 (5292) 0.003
Transport 613 (1018) 1315 (1123) b0.001
Domestic 1513 (2496) 1219 (2428) 0.801
Leisure 1269 (1607) 1565 (2134) 0.376
Activity type
Walking 1278 (1593) 2394 (2505) 0.004
Moderate 1256 (1802) 1645 (3223) 0.648
Vigorous 2170 (3560) 2787 (4242) 0.110
⁎ p values are differences betweenCF and non-CF group;Mann–WhitneyU test.were classified in high HPA category than their CF counterparts
but the association between HPA category (moderate and high)
and diagnosis (CF vs. non-CF) was not statistically significant
(p=0.22). There was no relationship between habitual physical
activity intensity category and demographic features such as age
and BMI in males with CF. In contrast, there was a significant
correlation between age and HPA accumulated from domestic
activities (r=0.55, p=0.005) and between BMI and moderate
activity accumulated HPA (r=−0.47, p=0.022) in females with
CF. The 8% in the CF group in the low HPA category (Fig. 1) did
not significantly differ from the rest of the CF group in terms of
age, BMI, and lung function.5. Discussion
Habitual physical activity (HPA) measured by the IPAQ was
compared between adult participants with CF and a control
group without CF. The study shows that 92% of those with CF
(vs. 95% of controls) classified in the moderate to high intensity
physical activity category of the IPAQ. The two groups were
also comparable on HPA accumulated from domestic and
leisure activities. Further, similarities between the groups were
observed in HPA accumulated from activities rated as moderate
or vigorous. The CF group had less physical activity in total
compared to their peers, as a result of lower levels of activity
associated with work and transport. This suggests that differences
in lifestyle and employment opportunities may impact on
physical activity levels.Fig. 1. Percentage of participants in each physical activity category based on
IPAQ total score (*pb0.001 chi-square goodness-of-fit test).
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employment, they accumulated fewer MET·min·week−1 than
their non-CF peers in this domain. Although our study showed
no significant difference in vigorous activity for work between
the groups, others have previously reported that patients with
CF tend to choose more sedentary vocations although lung
function may not be a significant limiting factor [19] which
may in some instances potentially contribute to fewer work-
related MET·min·week−1. Features such as shortness of breath,
fatigue, joint pain and cough have been cited as limiting factors
to physical exertion [20] and it has previously been noted that
CF has a bearing on one's choice of work and the extent of
participation in work [21,22]. It is likely that the lower energy
expenditure in work-related activity found in our study was a
result of fewer working hours for those with CF; however the
number of working hours was not recorded in this study.
Despite this, the findings of this study highlight the potential
role of engaging in employment and how it can benefit those
with CF by contributing to overall HPA levels.
It would appear that the lower total HPA in the adult CF
population in comparison to their non-CF peers continues a trend
that is established in adolescence. During childhood and early
adolescence, those with CF were found to compare favourably
with their non-CF peers on overall HPA although the CF cohorts
engaged less in vigorous activities [10]. Physical activity levels
declined over time, less physical activity in older adolescents
with CF compared to younger adolescents and healthy peers [13].
Despite the latter, our finding was that the CF adult population
was comparable to the non-CF population for vigorous physical
activity. This would suggest a reversal from earlier years when
children and adolescents engaged in less vigorous activities
compared to their healthy peers [10]. It is possible that this
reflects greater adherence to structured fitness programs in adults.
Although the proportion of individuals with CF who met the
physical activity recommendations [6] was not different to the
control group, there are currently no guidelines for the amount of
physical activity required to achieve health benefits in CF. It is
not known whether the threshold of 150 min per week of
moderate or vigorous activity is sufficient to accrue health
benefits in this population.
When the relationship between habitual physical activity and
lung function was explored regardless of gender, there appeared
to be no significant associations. However, when each gender
was evaluated separately, a significant association was observed
in females and not in males. For instance, performance of
vigorous habitual activity in females was positively and
moderately associated with FEV1, FVC and FEV1/FVC. A
previous study in the paediatric population showed a similar
association between habitual physical activity and FEV1 in
females [14]. Our study is the first to demonstrate that this
observation carries over into adulthood. It is not clear whether
lower lung function is a consequence of reduced physical
activity, or vice-versa. It remains to be seen whether interventions
that promote greater levels of physical activity among females
can preserve or slow the decline in lung function.
Males with CF in our study mostly reported activity levels in
the moderate to high intensity level, independent of lungfunction. The IPAQ gives prompts and examples of what are
considered moderate activities or vigorous activities. However,
perception and self rating of intensity may still be subjective; it
is possible that males may have overestimated activity levels in
order to provide socially desirable responses. It is also possible
that self-rated moderate to high intensity activities among males
in particular might be below the zone in which pulmonary
impairment begins to become an activity limiter. It is possible
that the HPA reported in the questionnaire was not of sufficient
intensity such as to reach aerobic thresholds for optimum
fitness. Therefore clinical practice still needs to encourage
regular moderate to high levels of physical activity in order to
promote health and fitness right into the adult CF population.
Exercise training is reported to work well under supervision
but the benefits are not sustained outside of regular structured
programs [5,7]. It was on this premise that Moorcroft et al. [7]
explored a long term unsupervised, individualised home-based
exercise program and they found positive exercise outcomes
that indicated unsupervised exercise was sustainable. However,
it must be borne in mind that this was still a trial conducted over
12 months; whether training and the benefits derived therein
can be sustained beyond the trial period remains unclear.
Habitual physical activity is unsupervised and encompasses
day to day activities, therefore less regimented and may be a
viable alternative way of accumulating physical activity or
supplement structured formal exercise. As such, Wilkes et al.
[5] argue that promoting HPA as part of lifestyle may be a
compliance enabler, hence offering the possibility of sustained
benefits compared to supervised exercise training programs.
Increased survival means that most people with CF will
survive into adulthood. With increased longevity, adults with
CF may live for long periods with comorbidities such as
CF-related diabetes [23] and may begin to develop age-related
chronic diseases. Regular physical activity is known to be
beneficial for all adults to reduce the risk of diabetes, heart
disease and cancer [24]. As the CF population becomes older, it
is important that health professionals consider the strategies
required to promote health behaviours and reduce disease risk
for the individuals in their care. The results of this study suggest
that in CF, more still needs to be done to achieve physical
activity of levels similar to the general population, with all the
attendant health benefits.
The study had a number of limitations. We measured
physical activity using a validated questionnaire but did not
obtain objective measures of HPA. However, we were able to
establish criterion validity of the IPAQ in our population. The
study sample consisted of 101 individuals who were recruited
prospectively and consecutively from our clinic, with demo-
graphic characteristics that did not differ from the remainder of
the clinic. However, participants who agreed to participate may
have had a greater interest in physical activity, thus masking the
true difference between the two groups under comparison. The
matched control group mostly consisted of healthcare pro-
fessionals who may already have positive attitudes and
awareness of physical activity, thus biasing their responses.
The control group was smaller than the group with CF and thus
it is possible that it did not fully represent HPA in the general
233T.M. Rasekaba et al. / Journal of Cystic Fibrosis 12 (2013) 229–233population. Despite these factors, our study provides new
insights into the physical activity habits of a relatively large
group of adults with cystic fibrosis.
6. Conclusion
Adults with CF performed similar levels of moderate and
vigorous physical activity as their peers. However, they undertook
less overall habitual physical activity, mainly as a result of reduced
physical activity during work and transport-related activities. The
impact of lifestyle and employment opportunities on physical
activity should be considered in people with CF. Structured,
regular physical activity of sufficient intensity should be
encouraged in order to optimise fitness.
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